AB&B BIO-TECH is a professional company dedicated to the research, development, production, and sales of human vaccines. With registered capital of 125 million RMB, the company represents a significant investment in the pharmaceutical industry, with total project investment valued at 400 million RMB. The project spans an area of 70 acres, featuring a planned construction area of 50,000 square meters, of which 30,000 square meters have already been completed.

Services include:
- Research and development of human vaccines
- Production of pharmaceutical products
- Sales and distribution of vaccines and related products
- Quality control and regulatory compliance services
- Consulting services for vaccine development

AB&B BIO-TECH is positioned as a key supplier in the pharmaceutical industry, contributing to advancements in vaccine technology and public health initiatives. For more information, please visit en.abbbio.com.